0001555280-21-000142.txt : 20210218 0001555280-21-000142.hdr.sgml : 20210218 20210218165600 ACCESSION NUMBER: 0001555280-21-000142 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210216 FILED AS OF DATE: 20210218 DATE AS OF CHANGE: 20210218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: David Glenn CENTRAL INDEX KEY: 0001606256 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35797 FILM NUMBER: 21650351 MAIL ADDRESS: STREET 1: C/O ZOETIS INC., 100 CAMPUS DRIVE CITY: FLORHAM PARK STATE: NJ ZIP: 07932 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zoetis Inc. CENTRAL INDEX KEY: 0001555280 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 460696167 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-822-7000 MAIL ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 4 1 wf-form4_161368534701322.xml FORM 4 X0306 4 2021-02-16 0 0001555280 Zoetis Inc. ZTS 0001606256 David Glenn C/O ZOETIS INC. 10 SYLVAN WAY PARSIPPANY NJ 07054 0 1 0 0 Chief Financial Officer Common Stock 2021-02-16 4 M 0 26285 73.24 A 59186 D Common Stock 2021-02-16 4 S 0 10000 168.21 D 49186 D Common Stock 2021-02-16 4 S 0 16285 169.35 D 32901 D Stock Option 2021-02-16 4 M 0 26285 0 D Common Stock 26285.0 69510 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2020. The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.98 to $168.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.00 to $169.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. 26,285 options granted February 13, 2018 at an exercise price of $73.24 per option. Each option vests on the third anniversary of the date of grant. Each option expires on the tenth anniversary of the date of grant. 7,712 options granted February 27, 2015 at an exercise price of $46.09 per option; 24,678 options granted February 12, 2019 at an exercise price of $87.51 per option; 18,794 options granted February 11, 2020 at an exercise price of $144.03 per option; and 18,326 options granted February 10, 2021 at an exercise price of $160.62 per option. /s/ Katherine H. Walden, as Attorney-in-Fact 2021-02-18